Micardis®. Observational Study in Patients With Essential Hypertension

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed to supplement, under conditions of usual clinical practice, the data on the efficacy and safety of Micardis® collected during the clinical studies.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Telmisartan

Criteria

Inclusion Criteria:

• Patients of either sex over the age of 18 years suffering from essential hypertension requiring treatment according to the physician

Exclusion Criteria:

• Hypersensitivity to the active component or to any of the excipients

• Pregnancy and lactation

• Biliary obstructive disorders

• Severe hepatic impairment

• Severe renal impairment